Maximum tumor diameter provides information before treatment

Categories: Winter 2022

Maximum tumor diameter on pretreatment MRI has the potential to provide further information to men with prostate cancer before definitive treatment.

This retrospective analysis included a cohort of 631 patients. Analysis identified 4 prognostic groups for patients treated with radical prostatectomy (RP), and 2 prognostic groups in those treated with radiotherapy. In the RP cohort, low/intermediate risk group patients with maximum tumor diameter 15 mm or more had significantly worse progression-free survival than those with maximum tumor diameter less than 14 mm. High-risk patients with radiographic extracapsular tumor extension had significantly worse progression-free survival than those without extracapsular extension. In the radical prostatectomy cohort, progression-free survival was significantly worse in the cohort with maximum tumor dimension 23 mm or more than those less than 23 mm.

Radiographic maximum tumor diameter may be a useful tool for patients with local/regional prostate cancer.

Dan mountain and poolpond p7
Breathe                                       © Dan Oldfield




Subscribe to Quest

"*" indicates required fields


This email address is only for subscribing or unsubscribing to or from Quest. Dr. Catalona cannot respond to questions concerning your Personal Health Information (PHI) that could identify you as an individual. This is a "cyber-security measure" for your protection that will help prevent anyone from legally or illegally accessing your personal health information.

Delivery Method (How do you want to receive your Quest publication?)*